OVERVIEW
The market for miRNA sequencing and assays is expected to hit USD 412 million by 2025, rising over the forecast period at a CAGR of 10.78%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increased funding for genomics research and rising sequencing costs.
TABLE OF CONTENT
1 Global MiRNA Sequencing and Assay Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global MiRNA Sequencing and Assay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global MiRNA Sequencing and Assay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global MiRNA Sequencing and Assay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global MiRNA Sequencing and Assay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global MiRNA Sequencing and Assay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global MiRNA Sequencing and Assay Market – By Product (Market Size – & million/billion)
8.1 Sequencing Consumables
8.2 Library Preparation Kits
9 Global MiRNA Sequencing and Assay Market – By Technology
9.1 Sequencing by Synthesis
9.2 Ion Semiconductor Sequencing
9.3 SOLiD
9.4 Nanopore Sequencing
10 Global MiRNA Sequencing and Assay Market – By End-User
10.1 Academic & Research Institutes
10.2 CROs
11 Global MiRNA Sequencing and Assay Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global MiRNA Sequencing and Assay Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global MiRNA Sequencing and Assay Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Illumina, Inc.
13.3 Thermo Fisher Scientific
13.4 Qiagen
13.5 Trilink Biotechnologies
13.6 Lexogen
13.7 Oxford Nanopore Technologies
13.8 Perkinelmer, Inc.
13.9 Norgen Biotek Corporation
13.10 Takara Bio, Inc.
13.11 New England Biolabs, Inc.
13.12 Company 11 & more
14 Global MiRNA Sequencing and Assay Market – Appendix
14.1 Sources
14.2 Abbreviations